The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA

Weller, Sandra; Toenniessen, Astrid; Schaefer, Benjamin; Beigl, Tobias; Muenchow, Alina; Bopple, Kathrin; Hofmann, Ute; Gillissen, Bernhard F.; Aulitzky, Walter E.; Kopp, Hans-Georg; Essmann, Frank

dc.contributor.author	Weller, Sandra
dc.contributor.author	Toennießen, Astrid
dc.contributor.author	Schäfer, Benjamin
dc.contributor.author	Beigl, Tobias
dc.contributor.author	Münchow, Alina
dc.contributor.author	Böpple, Kathrin
dc.contributor.author	Hofmann, Ute
dc.contributor.author	Essmann, Frank
dc.date.accessioned	2022-12-06T12:57:39Z
dc.date.available	2022-12-06T12:57:39Z
dc.date.issued	2022
dc.identifier.issn	2058-7716
dc.identifier.uri	http://hdl.handle.net/10900/133739
dc.language.iso	en	de_DE
dc.publisher	Springernature	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41420-022-01009-1	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_01134
utue.personen.roh	Weller, Sandra
utue.personen.roh	Toenniessen, Astrid
utue.personen.roh	Schaefer, Benjamin
utue.personen.roh	Beigl, Tobias
utue.personen.roh	Muenchow, Alina
utue.personen.roh	Bopple, Kathrin
utue.personen.roh	Hofmann, Ute
utue.personen.roh	Gillissen, Bernhard F.
utue.personen.roh	Aulitzky, Walter E.
utue.personen.roh	Kopp, Hans-Georg
utue.personen.roh	Essmann, Frank
dcterms.isPartOf.ZSTitelID	Cell Death Discovery	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	8	de_DE